-They have reduced or eliminated co-pays so no patient is paying as much out of pocket as they used to
-The drug is still 50% given away to people who cannot afford it
-The company ships drugs to patients before resolving disputes with insurance providers
-Shkreli's view is that it is in the best long term interests of the public to have a drug that can be insanely profitable be insanely profitable because it creates an incentive to create another better drug
-On that line, the company is researching new alternatives to the drug which are less toxic (ie: cannabalizing its own market)